Full Press Release Details
RETRACTABLE TECHNOLOGIES,
INC. DECLARES DIVIDENDS TO SERIES II AND III CLASS B PREFERRED STOCK SHAREHOLDERS
December 28, 2022 - Retractable Technologies, Inc. ("Retractable") (NYSE American: RVP) announced today that its Board
of Directors has declared dividends to holders of its Series II Class B and Series III Class B Convertible Preferred Stock in the amounts
of $39,050.00 and $19,061.25, respectively. Dividends have accrued at $1.00 per share per annum. The dividends cover the period beginning
October 1, 2022 through December 31, 2022. The dividends will be paid on January 20, 2023 to shareholders of record as of the close of
business on January 10, 2023.
Retractable manufactures
and markets VanishPoint and Patient Safe safety medical products and the EasyPoint needle.
The VanishPoint syringe, blood collection, and IV catheter products are designed to prevent needlestick injuries and
product reuse by retracting the needle directly from the patient, effectively reducing exposure to the contaminated needle. Patient Safe
syringes are uniquely designed to reduce the risk of bloodstream infections resulting from catheter hub contamination. The EasyPoint
is a retractable needle that can be used with luer lock syringes, luer slip syringes, and prefilled syringes to give injections.
The EasyPoint needle also can be used to aspirate fluids and for blood collection. Retractable's products are distributed
by various specialty and general line distributors.
For more information
on Retractable, visit its website at www.retractable.com.
statements in this press release are made pursuant to the safe harbor provision of the Private Securities Litigation Reform Act of 1995
and reflect Retractable's current views with respect to future events. Retractable believes that the expectations reflected in such forward-looking
statements are accurate. However, Retractable cannot assure you that such expectations will materialize. Actual future performance could
differ materially from such statements.
cause or contribute to such differences include, but are not limited to: the impact of supply chain and transportation delays on all
facets of logistics and operations as well as costs; Retractable's ability to scale up production volumes in response to an increase
in demand; potential tariffs; Retractable's ability to maintain liquidity; Retractable's maintenance of patent protection; Retractable's
ability to maintain favorable third party manufacturing and supplier arrangements and relationships; foreign trade risk; Retractable's
ability to access the market; production costs; the impact of larger market players in providing devices to the safety market; and other
risks and uncertainties that are detailed from time to time in Retractable's periodic reports filed with the U.S. Securities and Exchange
Retractable Technologies,
888-806-2626 or 972-294-1010
Chief Financial Officer, and Chief Accounting Officer